NIH-funded research R21 grant

IgA-producing plasma cells in the spleen: how gut microbes shape systemic immunity

Official title: Multikingdom generation and tissue maintenance of splenic IgA plasma cells

Funded at Univ of Massachusetts Med Sch Worcester · NIH-11463018 · Data updated 2026-11-12

This NIH grant explores how gut microbes influence special IgA-producing cells in the spleen to help keep both gut and body immunity balanced.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester
NIH-funded
Lab location1 site (Worcester, United States)
Project startSeptember 3, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$251,250
NIH project number1R21AI197056-01A1
Project IDNIH-11463018 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with conditions affecting IgA responses or gut-immune interactions, or healthy volunteers providing biological samples for translational insights.

Less likely to help

Participants with unrelated immune disorders or without involvement in IgA biology may not directly benefit.

What this research studies

This study looks at B cells that meet gut microbes and turn into IgA-secreting plasma cells, aiming to understand how these cells are formed and kept in the spleen. Researchers will examine signals from the gut environment that guide IgA plasma cell development and maintenance beyond the intestine. The project uses mouse models and human samples to map cellular interactions, transcriptional programs, and tissue niches that support IgA responses. The goal is to uncover the rules that connect gut microbiota to systemic antibody production and immune homeostasis.

Why it matters

Potential benefit: If successful, the findings could inform new ways to boost mucosal and systemic antibody defenses, potentially reducing infections and improving immune health.

How similar studies have gone: Prior work has linked gut microbiota to IgA production, but the specific splenic IgA plasma cell niche is a novel focus that may yield new insights.

Where this research is happening

  • Univ of Massachusetts Med Sch Worcester
    Worcester, United States
    Active

Researchers

  • Principal investigator: Reboldi, Andrea — Univ of Massachusetts Med Sch Worcester
  • Study coordinator: Reboldi, Andrea

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.